Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
DePuy Synthes
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
45.0%
+3.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:NeutralThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Stryker
Competitor Displacement Rate
40.0%
Competitors are displacing DePuy Synthes in 40.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Stryker's integrated surgical solutions and advanced implant technologies are gaining significant traction. DePuy Synthes may be perceived as having less innovative offerings, particularly in robotic-assisted surgery.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[stryker.com][zimmerbiomet.com]⚠️ Identified Vulnerability:Innovation
Primary Threat Identified:Stryker
Target Persona:Orthopedic Surgeons
🚨 Threat Velocity:8/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)